Sevoflurane and Hyperperfusion Syndrome

NCT02510586 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

152

Enrollment

OTHER

Sponsor class

Conditions

Hyperperfusion Syndrome
Moyamoya Disease

Interventions

DRUG: Sevoflurane

Sponsor

Seoul National University Hospital